Insider Transactions in Q4 2024 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
16,278
-1.92%
|
$16,278
$1.01 P/Share
|
|
Nov 19
2024
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,407
-2.84%
|
$6,407
$1.01 P/Share
|
|
Nov 19
2024
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
7,785
-3.1%
|
$7,785
$1.01 P/Share
|